Linda.Bunschoten

About Linda Bunschoten - Chief Marketing Officer

Linda has 25+ years of experience uncovering pain points and strategizing with companies in the healthcare industry in order to secure and retain more clients. Her chief thinking responsibilities include translating insight into strategy and ensure that all MarCom and Product Management activities contribute to our overall customer experience and meet our industry’s quality expectations.
Mar 2018

Blockchain in Clinical Trials – The Ultimate Data Notary

By |2022-12-02T14:45:07+02:00March 14, 2018|Free White Papers, News|Comments Off on Blockchain in Clinical Trials – The Ultimate Data Notary

Blockchain technology is the biggest achievement in cryptography of the past decade. Source Data Verification (SDV), which consumes about 20–30% of the clinical trial budget nowadays, will become redundant when blockchain technology disrupts the pharma industry.

Feb 2018

Webinar | Best Practices in Defining KRIs for Clinical Trials

By |2020-09-23T10:04:26+02:00February 13, 2018|News|Comments Off on Webinar | Best Practices in Defining KRIs for Clinical Trials

Are your role connected with the controlling the quality, performance or risks of clinical trials? We are delighted to invite you along to this exclusive live webinar and Q&A session on February 23rd, 2018.

Feb 2018

Dr Nimita Limaye: “KRI Wiki is a Path Breaking Initiative”

By |2018-02-12T11:14:09+02:00February 7, 2018|Neat Features, News|Comments Off on Dr Nimita Limaye: “KRI Wiki is a Path Breaking Initiative”

We are pleased to welcome Dr Nimita Limaye, Project Lead KRI Wiki, to the Cyntegrity team! Key Risk Indicators (KRIs) play a fundamental role in managing risk, you could say they are the “traffic lights” of clinical monitoring. When appropriately selected and calibrated KRIs [...]

Jan 2018

Fake news, fake likes, fake quotes: who or what can I trust these days?

By |2020-09-23T08:44:13+02:00January 4, 2018|Blog|Comments Off on Fake news, fake likes, fake quotes: who or what can I trust these days?

There is a rapidly growing amount of information to process in clinical research. You could argue whether it adds value viewing and verifying the reliability of each single data point. Dirty data and frauds have always existed but can eventually be marginalised by responsive people and processes.

Jan 2018

Newsletter: Fast-advancing science has opened the era of personalized medicine

By |2018-01-02T08:37:06+02:00January 2, 2018|News|Comments Off on Newsletter: Fast-advancing science has opened the era of personalized medicine

More than ever before, well-designed clinical trials are essential to maximize chances of success.

Dec 2017

Newsletter: Start 2018 with an easier way to manage your clinical risks

By |2017-12-13T13:58:18+02:00December 11, 2017|News|Comments Off on Newsletter: Start 2018 with an easier way to manage your clinical risks

100% SDV...seriously, who DOES this? Start 2018 with an easier way to manage your clinical risks.

Dec 2017

Lean Six Sigma, a different term for the same concept

By |2020-09-23T09:08:21+02:00December 5, 2017|Blog|Comments Off on Lean Six Sigma, a different term for the same concept

Believe it or not, it was Guinness’ biochemist Gosset who developed the first Six Sigma statistical test in the early 1900s. The Guinness brewery was far ahead of its time by hiring statisticians, chemists and other scientists to improve the quality of its beer.

Nov 2017

Implementing RBM – Moving out of your comfort zone

By |2020-09-23T08:47:39+02:00November 23, 2017|Blog|Comments Off on Implementing RBM – Moving out of your comfort zone

“There are always a million reasons not to do something” A great inspiring quote from Jan on an episode of The Office when Pam was making excuses not to go to Art school. A very recognisable habit, isn’t it? Talking ourselves out of doing [...]

Go to Top